Cargando…

Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.

Four human cell lines derived from malignant gliomas were immunohistochemically examined for their content of estramustine-binding protein (EMBP). EMBP was detected in a large amount in all glioma cells during the entire cell cycle. EMBP has previously been demonstrated to be the major receptor prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Schoultz, E., Lundblad, D., Bergh, J., Grankvist, K., Henriksson, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246581/ https://www.ncbi.nlm.nih.gov/pubmed/3052561

Ejemplares similares

Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
por: Bergenheim, A. T., et al.
Publicado: (1993)

Effects of radiotherapy and estramustine on the microvasculature in malignant glioma
por: Johansson, M, et al.
Publicado: (1999)

DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death.
por: Vallbo, C., et al.
Publicado: (1995)

Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.
por: Behnam-Motlagh, P., et al.
Publicado: (1997)

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience
por: Nakano, Kazuhiko, et al.
Publicado: (2012)

Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer
por: Albrecht, W, et al.
Publicado: (2004)

Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.
por: Speicher, L. A., et al.
Publicado: (1991)

Comparison of Ketoconazole and Estramustine for Treating Patients with Castration-Resistant Prostate Cancer
por: Yun, Bu Hyeon, et al.
Publicado: (2011)

Marked leukocytosis in response to estramustine phosphate in a hormone-refractory prostate cancer patient
por: Morita, Tatsuo
Publicado: (2010)

Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
por: Hernes, E. H., et al.
Publicado: (1997)

Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells
Publicado: (1988)

Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis
por: Qin, Zhiqiang, et al.
Publicado: (2016)

Estramustine Phosphate Inhibits TGF-β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production
por: Mojsilovic, Sonja S., et al.
Publicado: (2018)

Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer
por: Galli, L, et al.
Publicado: (2007)

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study
por: Carles, J, et al.
Publicado: (2007)

A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899
por: DiPaola, Robert S, et al.
Publicado: (2010)

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer
por: Narita, Shintaro, et al.
Publicado: (2012)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Anti-proliferative and cytotoxic effect of cannabidiol on human cancer cell lines in presence of serum
por: Sainz-Cort, Alberto, et al.
Publicado: (2020)

Polysaccharide peptide isolated from grass-cultured Ganoderma lucidum induces anti-proliferative and pro-apoptotic effects in the human U251 glioma cell line
por: Wang, Chunhua, et al.
Publicado: (2018)

Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro.
por: Eliason, J. F., et al.
Publicado: (1993)

In vitro anti-proliferative activity of selected nutraceutical compounds in human cancer cell lines
por: Nibret, Endalkachew, et al.
Publicado: (2021)

Anti-proliferative activity of Artemisia marschalliana on cancerous cell lines
por: Forouhandeh, Haleh, et al.
Publicado: (2023)

Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines
por: Lee, Do Kyung, et al.
Publicado: (2008)

Anti-proliferative effect of Flos Albiziae flavonoids on the human gastric cancer SGC-7901 cell line
por: YUAN, JIANMEI, et al.
Publicado: (2013)

Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562.
por: Hoffman, R., et al.
Publicado: (1989)

The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas
por: Senft, Christian, et al.
Publicado: (2010)

Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
por: Linderholm, B, et al.
Publicado: (1999)

Anti-Proliferative Effects of Methanol and Water Extracts of Pyrrosia piloselloides on the Hela Human Cervical Carcinoma Cell Line
por: ‘ain, Mohd Dasuki Sul, et al.
Publicado: (2019)

Anti-proliferative and apoptotic effects of hull-less pumpkin extract on human papillary thyroid carcinoma cell line
por: Bahadori, Mohammad Hadi, et al.
Publicado: (2021)

Imidazopyridazine Acetylcholinesterase Inhibitors Display Potent Anti-Proliferative Effects in the Human Neuroblastoma Cell-Line, IMR-32
por: Sharma, Rakesh Kumar, et al.
Publicado: (2021)

Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines
por: Zou, Zhengyun, et al.
Publicado: (2012)

Polish Natural Bee Honeys Are Anti-Proliferative and Anti-Metastatic Agents in Human Glioblastoma multiforme U87MG Cell Line
por: Moskwa, Justyna, et al.
Publicado: (2014)

Pooled screening for anti-proliferative inhibitors of protein-protein interactions
por: Nim, Satra, et al.
Publicado: (2016)

Anti-proliferative activity of Fumaria vaillantii extracts on different cancer cell lines
por: Tabrizi, Fatemeh Haji Abbas, et al.
Publicado: (2016)

Composition of Triterpenoids in Inonotus obliquus and Their Anti-Proliferative Activity on Cancer Cell Lines
por: Kim, Jaecheol, et al.
Publicado: (2020)

Anti-Oxidative and Anti-Proliferative Activity on Human Prostate Cancer Cells Lines of the Phenolic Compounds from Corylopsis coreana Uyeki
por: Kim, Manh Heun, et al.
Publicado: (2013)

In Search of Outliers. Mining for Protein Kinase Inhibitors Based on Their Anti-Proliferative NCI-60 Cell Lines Profile
por: Ion, George Nicolae Daniel, et al.
Publicado: (2020)

Reduced Selenium-Binding Protein 1 in Breast Cancer Correlates with Poor Survival and Resistance to the Anti-Proliferative Effects of Selenium
por: Zhang, Sheng, et al.
Publicado: (2013)

Anti-Proliferative Effects of Evodiamine in Human Lung Cancer Cells
por: Hong, Ji-Young, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ticg9cq43barmjop2b139hinu1